Skip to main content
. 2020 May 15;11:722. doi: 10.3389/fphar.2020.00722

Figure 1.

Figure 1

Identification of PD-1/PD-L1. The binding of TCR and MHC activates adaptive immune response. The binding of PD1 and PD-L1 can prevent the signaling transduction of T cells to inhibit the immune response, while anti-PD-1/PD-L1 antibody can reverse the inhibition. TCR, T cell receptor.